Approval · Notice of Compliance 4755 · 1995
DIFFERIN: Notice of Compliance 4755
Issued January 24, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4755
- Date
- January 24, 1995
- Company
- Galderma Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Acne therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DIFFERIN | Not yet assigned | — |
Medicinal ingredients
- ADAPALENE 0.1 PER